Rapport Therapeutics, Inc. Common Stock (RAPP)

18.83

(-1.26%)

Net Debt Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual net debt in 2023 was -68.1 Million USD , down -118.58% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly net debt in 2024 Q2 was -108.44 Million USD , down -49.82% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported annual net debt of -31.15 Million USD in 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly net debt of -72.38 Million USD for 2024 Q1, down -6.42% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly net debt of -68.1 Million USD for 2023 FY, down -118.58% from previous quarter.

Annual Net Debt Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Net Debt of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Net Debt Net Debt Growth
2023 -68.1 Million USD -118.58%
2022 -31.15 Million USD 0.0%

Peer Net Debt Comparison of Rapport Therapeutics, Inc. Common Stock

Name Net Debt Net Debt Difference